Table 3.
Treatments and outcomes in patients with coronavirus disease 2019 (covid-19) on admission to hospital in Zhejiang province, China. Values are numbers (percentages) of patients
| Treatments and outcomes | All patients (n=62) | Time since symptom onset | |
|---|---|---|---|
| >10 days (n=33) | ≤10 days (n=29) | ||
| Admission to intensive care unit | 1 (2) | 1 (3) | 0 (0) |
| Acute respiratory distress syndrome | 1 (2) | 1 (3) | 0 (0) |
| Treatment | |||
| Antiviral treatment | 55 (89) | 31 (94) | 24 (83) |
| Interferon alpha inhalation | 8 (13) | 4 (12) | 4 (14) |
| Lopinavir/ritonavir | 4 (6) | 3 (9) | 1 (3) |
| Arbidol+interferon alpha inhalation | 1 (2) | 0 (0) | 1 (3) |
| Lopinavir/ritonavir+interferon alpha inhalation | 21 (34) | 7 (21) | 14 (48) |
| Arbidol+lopinavir/ritonavir | 17 (28) | 13 (39) | 4 (14) |
| Arbidol+lopinavir/ritonavir+interferon alpha inhalation | 4 (6) | 4 (12) | 0 (0) |
| Antibiotics | 28 (45) | 16 (48) | 12 (41) |
| Corticosteroid and gamma globulin | 16 (26) | 11 (33) | 5 (17) |
| Prognosis | |||
| Hospital admission | 61 (98) | 32 (97) | 29 (100) |
| Discharge | 1 (2) | 1 (3) | 0 (0) |
| Death | 0 | 0 | 0 |
Percentages do not total 100% owing to missing data.